Stockscreener 앱 받기
0.834
4.36%
-0.038
시간 외 거래:
.84
0.006
+0.72%
전일 마감가:
$0.872
열려 있는:
$0.87
하루 거래량:
842.93K
Relative Volume:
0.74
시가총액:
$107.73M
수익:
-
순이익/손실:
$-26.91M
주가수익비율:
-3.7909
EPS:
-0.22
순현금흐름:
$-19.57M
1주 성능:
-3.24%
1개월 성능:
+0.48%
6개월 성능:
-0.94%
1년 성능:
-38.22%
1일 변동 폭
$0.8211
$0.8749
1주일 범위
$0.8068
$0.984
52주 변동 폭
$0.5526
$1.66
Atossa Therapeutics Inc Stock (ATOS) Company Profile
명칭
Atossa Therapeutics Inc
전화
206.588.0256
주소
10202 5TH AVENUE NE, SEATTLE, WA
ATOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATOS
Atossa Therapeutics Inc
|
0.834 | 112.64M | 0 | -26.91M | -19.57M | -0.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Atossa Therapeutics Inc Stock (ATOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-01-26 | 개시 | Maxim Group | Buy |
Atossa Therapeutics Inc 주식(ATOS)의 최신 뉴스
What recovery options are there for Atossa Therapeutics Inc.Smart Safety Strategy With Real Data Analysis - Newser
Is Atossa Therapeutics Inc. a growth stock or a value stockRetirement Planning Updates For Consistent Profits - jammulinksnews.com
What are Atossa Therapeutics Inc. company’s key revenue driversAI Powered Entry Points From AI Tools - jammulinksnews.com
Leading vs lagging indicators on Atossa Therapeutics Inc. performanceHigh Return Trade Roadmap with Setup Filters - Newser
What the charts say about Atossa Therapeutics Inc. todayChart Risk Profile for Capital Preservation - Newser
Atossa Therapeutics Inc. stock momentum explainedFree Trade Setups With AI Powered Filters - Newser
Is Atossa Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideMomentum Detection with Entry Optimization - Newser
Atossa Therapeutics Shares Surge 13.14% on FDA Validation of (Z)-Endoxifen Strategy - AInvest
Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinical Program in ER+/HER2- Metastatic Breast Cancer - BioSpace
Identifying reversal signals in Atossa Therapeutics Inc.Weekly Growth Portfolio Performance Summary - Newser
Why Atossa Therapeutics Inc. stock attracts strong analyst attentionWeekly High Conviction Trade Setup Analysis - Newser
Atossa Therapeutics stock jumps after FDA provides positive feedback By Investing.com - Investing.com Canada
Atossa Therapeutics stock jumps after FDA provides positive feedback - Investing.com
FDA Green Lights Atossa's Novel Breast Cancer Drug Strategy: Key Development Milestones Revealed - Stock Titan
Will Atossa Therapeutics Inc. benefit from macro trendsReal-Time Signal Tracking with Entry Level - Newser
How volatile is Atossa Therapeutics Inc. stock compared to the marketFree Investment Portfolio Suggestions - jammulinksnews.com
What catalysts could drive Atossa Therapeutics Inc. stock higher in 2025Advanced Screener Planner For Consistent Profits - jammulinksnews.com
Multi asset correlation models including Atossa Therapeutics Inc.Free Fundamental Growth Stock Analysis - Newser
When is Atossa Therapeutics Inc. stock expected to show significant growthAccelerated profit realization - jammulinksnews.com
What is Atossa Therapeutics Inc. company’s growth strategyReal Time Watchlist With Proven Results - jammulinksnews.com
What makes Atossa Therapeutics Inc. stock price move sharplyGet alerts on the hottest market movers - jammulinksnews.com
How does Atossa Therapeutics Inc. compare to its industry peersGet timely alerts on market movers - jammulinksnews.com
New Product Launches: Will They Boost Atossa Therapeutics Inc. Stock in 2025ROI Driven Alerts - Newser
Is Atossa Therapeutics Inc. a good long term investmentHigh-impact investment strategies - PrintWeekIndia
Atossa Therapeutics Inc. Stock Analysis and ForecastHigh-performance investment picks - PrintWeekIndia
What analysts say about Atossa Therapeutics Inc. stockFree Market Volatility Navigation Tips - Autocar Professional
Does Atossa Therapeutics Inc. stock pay reliable dividendsPowerful profit generation - jammulinksnews.com
What drives Atossa Therapeutics Inc. stock priceDynamic investment opportunities - PrintWeekIndia
Will Atossa Therapeutics Inc. stock split in the near futureDynamic investment growth - jammulinksnews.com
How Atossa Therapeutics Inc. stock reacts to Fed policy changesStrongest growth potential - jammulinksnews.com
Atossa Therapeutics Inc (ATOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.43%
2.00%
자본화:
|
볼륨(24시간):